ZTS

Zoetis Inc
NYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$32.24B
P/E Ratio
12.61
EPS
$6.07
Beta
0.75
52W High
$158.55
52W Low
$71.47
50-Day MA
$78.27
200-Day MA
$113.88
Dividend Yield
2.64%
Profit Margin
28.00%
Forward P/E
11.25
PEG Ratio
1.84

About Zoetis Inc

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$9.53B
Gross Profit (TTM)$6.85B
EBITDA$4.07B
Operating Margin36.60%
Return on Equity67.70%
Return on Assets15.50%
Revenue/Share (TTM)$21.81
Book Value$7.84
Price-to-Book9.97
Price-to-Sales (TTM)3.37
EV/Revenue4.149
EV/EBITDA9.73
Quarterly Earnings Growth (YoY)6.00%
Quarterly Revenue Growth (YoY)2.90%
Shares Outstanding$419.23M
Float$418.38M
% Insiders0.15%
% Institutions102.23%

Historical Volatility

HV 10-Day
22.44%
HV 20-Day
31.33%
HV 30-Day
31.27%
HV 60-Day
59.32%
HV Rank
73.4%

Volatility is currently contracting

Analyst Ratings

Consensus ($114.76 target)
3
Strong Buy
8
Buy
9
Hold

Latest News

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).

GlobeNewsWire7/16/2026Neutral
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. Lawsuit - ZTS

Wall Street's Reassessment of Zoetis Accelerated as Analyst Downgrades Followed Each Corrective Disclosure, Reflecting Growing Skepticism That Management's Companion Animal Growth Narrative Was Built on Concealed Competitive and Safety Deterioration NEW YORK, July 16, 2026 /PRNewswire/ -- Sell-side coverage of Zoetis Inc. (NYSE: ZTS) shifted dramatically over a nine-month span successive revelations forced analysts to reprice the animal health leader's growth assumptions. SueWallSt notifies investors who purchased ZTS securities between January 14, 2025 and May 6, 2026 that a securities class action has been filed.

PRNewsWire7/16/2026Neutral
ZOETIS INC. (ZTS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Zoetis Inc. Investors of Upcoming Deadline

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors of the  July 27, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Zoetis Class Action Lawsuit : Do you, or did you, own shares of Zoetis Inc. (NYSE: ZTS)?

GlobeNewsWire7/16/2026Neutral
Zoetis Deadline: ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK, July 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. So What: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

PRNewsWire7/16/2026Neutral
ZOETIS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp7/16/2026Neutral
Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact KTMC

Did you buy ZTS securities between January 14, 2025, and May 6, 2026? Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS) What: Securities fraud class action lawsuit filed Class Period: January 14, 2025 through May 6, 2026 Deadline to Seek Lead Plaintiff Status: July 27, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's product adoption.

PRNewsWire7/15/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ZTS and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/18/2026